三月 2026
- Home
- Cerba Research
三月 2026的Cerba Research市场份额分析
World-class clinical research that helps life science companies to successfully develop the predictive and precision medicines of the future.
Cerba Research(包含公司地区分支机构)
查看更多网站流量和参与度信息- cerbaresearch.com
Cerba Research收入截至 三月 2026为 25M - 50M
Cerba Research主要域名产生的收入
3 年中Cerba Research主要域名的收入
Cerba Research主要域名的收入
Cerba Research热门域名的总访问量
了解Cerba Research市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Cerba Research热门域名的平均访问时长
分析Cerba Research参与度指标。
过去 3 个月的平均访问时长
子公司明细
Cerba Research热门域名的平均页面浏览量
了解Cerba Research如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Cerba Research 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Cerba Xpert partnered with Ozette Technologies, Inc. on Apr 16th '26.Paris, France and Seattle, WA - April 16, 2026 - Cerba Research, a global leader in specialty laboratory services and translational research, today announced a strategic partnership with Ozette Technologies, Inc. (Ozette), an innovator in high-dimensional spectral flow cytometry and AI-driven single-cell data analytics.
四月 16, 2026阅读更多
新闻Cerba HealthCare Group acquires Cerba Xpert.Life science: Cerba HealthCare to acquire Canadian contract Research Laboratory CIRION BioPharma Research to expand bioanalytical capabilities and shorten time-to-deploy complex Clinical trials.
九月 6, 2023阅读更多
新闻Cerba Xpert launched tools to improve R&D for vaccine development against infectious diseases, including COVID-19 on Jan 1st '21.In 2021, Cerba Research announced the launch of new tools to improve R&D for vaccine development against infectious diseases, including COVID-19.
一月 5, 2023阅读更多
查看 Cerba Research 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
